AUS
NZ
UK
CA
USA
IND
On 3 July 2026, AMA Group Limited (ASX:AMA), a leading Australian automotive repair and services firm, issued 218,340 unquoted Restricted Rights to three key management personnel as part of its Non-Executive Director Equity Plan. Each Restricted Right grants the holder entitlement to one fully paid ordinary share in AMA Group, implying a potential dilution impact on current shareholders. This issuance was executed under an exemption from ASX Listing Rule 7.2, requiring no immediate shareholder approval, as prior consent was obtained at the company’s Annual General Meeting on 3 November 2025. The issuance underlines AMA Group’s ongoing strategy to use equity-based incentives to align non-executive directors’ interests with those of long-term shareholders.
Key Points
- Company: AMA Group Limited (ASX:AMA)
- 218,340 Restricted Rights (ASX code: AMAAF) issued on 3 July 2026 under the Non-Executive Director Equity Plan
- Recipients: Brian Austin (72,780), Joanne Dawson (72,780), Anthony Clark (72,780) — all key management personnel
- Each Restricted Right converts into one fully paid ordinary share upon vesting
- Issue approved under ASX Listing Rule 7.2 exemption, with shareholder approval granted at the 3 November 2025 AGM
- Post-issuance, total unquoted Restricted Rights stand at 345,640, alongside 481,267,050 ordinary shares on issue
- Investors should monitor vesting conditions and any future equity issuances under the Non-Executive Director Equity Plan
Details of AMA Group’s 3 July 2026 Restricted Rights Issuance Under the Non-Executive Director Equity Plan
AMA Group Limited confirmed the issuance of 218,340 Restricted Rights under its Non-Executive Director Equity Plan on 3 July 2026. These unquoted securities, trading under the ASX code AMAAF, represent conditional rights that convert into fully paid ordinary shares upon meeting specified vesting criteria.
The issuance was officially disclosed in an Appendix 3G lodged with the ASX on 3 July 2026, which detailed the issue date and recipients. This filing, classified as a new announcement, indicates that this issuance had not been previously reported through an Appendix 3B.
Equal Distribution of 72,780 Restricted Rights to Brian Austin, Joanne Dawson, and Anthony Clark
The 218,340 Restricted Rights were evenly allocated among three key management personnel: Brian Austin, Joanne Dawson, and Anthony Clark, each receiving 72,780 Restricted Rights. The securities are registered in each individual’s name, consistent with the plan’s objective of providing equity-based remuneration to the company’s non-executive directors.
This equal allocation suggests a standardized approach rather than performance-based differentiation, aligning with common practices for non-executive director equity plans on the ASX. The specific vesting conditions for this tranche are detailed in the Non-Executive Director Equity Plan, summarized on pages 12 to 15 of AMA Group’s 2025 Notice of Annual General Meeting.
Implications of Each Restricted Right for AMA Group Shareholders
Each Restricted Right entitles the holder to one fully paid ordinary share in AMA Group upon vesting. Consequently, the 218,340 Restricted Rights issued represent a potential increase of the same number of ordinary shares in the company’s capital, contingent on the satisfaction of vesting conditions.
While the number of shares is modest relative to the total issued ordinary shares of 481,267,050, shareholders should consider the cumulative effect of all unquoted equity securities, including performance rights, when evaluating dilution risks. The company did not disclose the exact vesting schedule or conditions for this issuance in the update.
AMA Group’s Unquoted Securities Position After the July 2026 Issuance
Following this issuance, AMA Group’s total unquoted securities comprise 345,640 Restricted Rights (AMAAF) and 13,609,044 Performance Rights (AMAAK). The company’s ordinary shares on issue remain at 481,267,050. The update notes that these figures may not fully reflect the current issued capital if other filings are being processed concurrently by the ASX.
The combined pool of unquoted securities, totaling approximately 13,954,684, represents a significant but typical potential dilution level for a company of AMA Group’s scale. The AMAAK Performance Rights were not the subject of this announcement, and no further details were provided regarding that class.
Shareholder Approval and Regulatory Compliance
The issuance was conducted under an exemption in ASX Listing Rule 7.2, which allows equity issues under an employee incentive scheme without additional shareholder approval, provided the scheme has been approved within the past three years. AMA Group secured this approval at its Annual General Meeting on 3 November 2025.
The terms of the Non-Executive Director Equity Plan, as approved, are publicly available in the 2025 Notice of Annual General Meeting on AMA Group’s website. This governance process ensures shareholder oversight of the equity incentive framework, even though individual issuances do not require separate votes.
Role of the Non-Executive Director Equity Plan in AMA Group’s Remuneration Strategy
The plan aims to align non-executive directors’ interests with those of shareholders by providing equity-based remuneration, fostering long-term commitment and performance. Issuing Restricted Rights rather than outright shares allows AMA Group to impose vesting conditions such as tenure or performance hurdles before conversion.
This structure means the dilutive effect is conditional, and not all Restricted Rights may ultimately vest. Specific vesting details for this tranche were not disclosed in the update.
Context Within AMA Group’s Capital Structure and Incentive Framework
With 481,267,050 ordinary shares outstanding, AMA Group is a significant ASX-listed entity in the automotive services sector. The use of equity incentives extends beyond non-executive directors, with 13,609,044 Performance Rights (AMAAK) outstanding for other key personnel, forming part of a comprehensive leadership incentive program.
The 218,340 Restricted Rights issued represent roughly 0.045% of the company’s ordinary shares, a relatively minor proportion. The immediate market impact of this issuance was not detailed in publicly available information.
Regulatory Disclosure and Appendix 3G Filing
The Appendix 3G filing is a standard ASX requirement for reporting unquoted equity securities issued under employee or director incentive schemes. It discloses the number of securities, issue date, recipients, and confirms that the new securities rank equally with existing securities in the same class.
AMA Group confirmed the 218,340 Restricted Rights issued on 3 July 2026 rank equally with the 127,300 previously issued Restricted Rights in the AMAAF class, bringing the total to 345,640. This compliance aligns with AMA Group’s regulatory obligations as an ASX-listed company.
Investor Considerations and Outlook for AMA Group’s Equity Incentive Plan
Investors should monitor the vesting and conversion of the 345,640 Restricted Rights outstanding, as each conversion will incrementally increase the company’s share count and dilute existing holdings. Detailed vesting timelines and conditions are available in the 2025 Notice of Annual General Meeting on the company’s website.
The announcement indicates that the Non-Executive Director Equity Plan remains an active component of AMA Group’s remuneration approach in the latter half of 2026. Future issuances, plan amendments, or vesting updates will be communicated through subsequent regulatory disclosures. The key upcoming event for stakeholders is the determination of vesting outcomes for current and prior AMAAF Restricted Rights tranches, which will define the plan’s ultimate impact on share capital.
